4
Changes in Ownership
AXIM BIOTECHNOLOGIES, INC. Filed Acc 0001514955-14-000004
PRESIDENT, CEO, CFO sold 21,000,000 shares at an average $7,638.10 ($160,400,000,000)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| SAMUELS ROSEMARY PRESIDENT, CEO, CFO | 2014-03-21 | Sale | −20,000,000 | $8,000.00 | $160,000,000,000 | 0 | D |
| SAMUELS ROSEMARY PRESIDENT, CEO, CFO | 2014-03-21 | Sale | −1,000,000 | $400.00 | $400,000,000 | 0 | D |
| Open-market sales · 21,000,000 sh · avg $7,638.10 · $160,400,000,000 | |||||||
Loading xslF345X03/primary_doc.xml…